Poolbeg Pharma "really open" to different types of deal for POLB 001
By:
TheNewswire.com
March 01, 2023 at 03:40 AM EST
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) VP of Business Development David English speaks to Proactive's Thomas Warner about the work he's doing to progress the clinical stage infectious disease pharmaceutical company's lead asset POLB 001.
English says that Poolbeg is "in a good position" for partnering in general, adding that the company is "really open" to different types of deals for lead asset POLB 001.
Contact Details
Proactive UK Ltd
+44 20 7989 0813
More News
View More
D-Wave: Time to Buy the Dip? Or is the Fall Just Starting? ↗
November 24, 2025
Via MarketBeat
Tickers
QBTS
Hims, Block, and NRG Just Launched Huge Stock Buybacks ↗
November 24, 2025
Via MarketBeat
Retail Earnings Roundup: Walmart Scores, Target Slumps in Q3 ↗
November 24, 2025
Via MarketBeat
Via MarketBeat
Why Circle Stock Is Falling—and Why Some Analysts See Big Upside ↗
November 24, 2025
Via MarketBeat
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>